Corvus Pharmaceuticals
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell CRVS and other ETFs, options, and stocks.About CRVS
Corvus Pharmaceuticals, Inc. engages in the development of product candidates for the treatment of cancer and immune-mediated and inflammatory diseases. Its product candidates include soquelitinib, an ITK inhibitor, ciforadenant, an adenosine A2A receptor antagonist, and mupadolimab, a B cell-activating anti-CD73 antibody.
CRVS Key Statistics
Stock Snapshot
Corvus Pharmaceuticals(CRVS) stock is priced at $14.80, giving the company a market capitalization of 1.22B. It carries a P/E multiple of -23.41.
On 2026-08-23, Corvus Pharmaceuticals(CRVS) stock moved within a range of $14.35 to $14.80. With shares now at $14.80, the stock is trading +3.1% above its intraday low and 0.0% below the session's peak.
Trading activity shows a volume of 473.79K, compared to an average daily volume of 783.41K.
Over the past 52 weeks, Corvus Pharmaceuticals(CRVS) stock has traded between a high of $26.95 and a low of $5.22.
Over the past 52 weeks, Corvus Pharmaceuticals(CRVS) stock has traded between a high of $26.95 and a low of $5.22.
CRVS News
Corvus Pharmaceuticals Inc. ((CRVS)) has held its Q2 earnings call. Read on for the main highlights of the call. Summer Sale - Claim 70% Off TipRanks Unlock pow...
In August 2026, Corvus Pharmaceuticals, Inc. reported second-quarter 2026 results showing a net loss of US$17.96 million, or US$0.19 per basic and diluted share...
Analyst ratings
100%
of 8 ratingsPeople also own
Similar Marketcap
This list is generated by looking at the six larger and six smaller companies by market cap in relation to this company.
Popular Stocks
This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset
Newly Listed
This list is generated by showing companies that recently went public.